Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.
about
Periodontal disease: linking the primary inflammation to bone lossAnti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities.A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations.Serum bone biomarkers and oral/systemic bone loss in humansEffects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J miceNon-antibacterial tetracycline formulations: clinical applications in dentistry and medicineAntimicrobial or subantimicrobial antibiotic therapy as an adjunct to the nonsurgical periodontal treatment: a meta-analysis.Biotic acts of antibioticsOsteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.New approaches to selectively target cancer-associated matrix metalloproteinase activity.Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.Evaluation of the effects of two different bone resorption inhibitors on osteoclast numbers and activity: An animal study.Doxycycline treatment in dialysis related amyloidosis: discrepancy between antalgic effect and inflammation, studied with FDG-positron emission tomography: a case reportA novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.Porous PCL/Chitosan and nHA/PCL/Chitosan Scaffolds for Tissue Engineering Applications: Fabrication and Evaluation
P2860
Q26995381-5F43F1E9-873F-4A5A-B14A-85F4F0FE060DQ33815397-2E050F34-4806-4E7A-8E6A-DEE9A3F94BFBQ33912089-EF63D9D0-5601-474B-AA18-86E3F6C4223DQ34975430-4C19B5F7-BF68-4BC7-AF9A-904B9096A4D9Q35073214-55E51D78-DC44-45DC-9644-432FEEBC19EEQ36317523-AC714963-BF2B-4748-AACC-1EB3FA707904Q36361191-077A2137-0E8C-4076-AEB7-7CAEEC4D2CEBQ37101851-7AD4A917-57E9-4901-995D-F9303F2B9859Q37266142-C0C09CF9-66F5-4818-B5AA-856288FE2BF7Q38261141-27635933-CFE2-4558-8138-B05E39C7C49CQ38786719-CBFD56D8-8B42-4BE6-9D7A-31DB914A0315Q38969971-24D8FAD6-9269-46FD-84F1-412BF00C5C3FQ41625514-0B645353-A58A-4BBC-B18F-0FFCF01513D4Q53767295-41A38525-5278-4D48-98AA-638D74E7BABEQ59113358-BC7A095F-D57C-4703-A436-F7CF0D50BFEF
P2860
Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@ast
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@en
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@nl
type
label
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@ast
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@en
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@nl
prefLabel
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@ast
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@en
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@nl
P2860
P1476
Using tetracyclines to treat o ...... ence laboratory to the clinic.
@en
P2093
Jeffrey B Payne
Lorne M Golub
P2860
P304
P356
10.1016/J.PHRS.2010.10.006
P577
2010-10-16T00:00:00Z